Showing results (1701-1710 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|April 12, 2025
Use of alternative and confirmatory data in support of rare disease drug developmentShein-Chung Chow, Anne Pariser, Steven GalsonJournal of Biopharmaceutical Statistics|April 17, 2025
A Bayesian approach for studying COVID-19 contagion dynamics in Algeria using a Poisson autoregressive (PAR) modelAhmed Hamimes, Hani Amir Aouissi, Feriel Kheira Kebaili, et al.Journal of Biopharmaceutical Statistics|April 17, 2025
PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical dataYuansong Zhao, Peng Yang, Glen Laird, et al.Journal of Biopharmaceutical Statistics|April 23, 2025
An improved biomarker-guided adaptive patient enrichment design for oncology trialsZhenwei Zhou, Zhaoyang Teng, Jian Zhu, et al.Journal of Biopharmaceutical Statistics|April 20, 2025
Joint modeling of longitudinal endpoints and its applications to trial planning, monitoring and analysisLiangcai Zhang, George Capuano, Vladimir Dragalin, et al.Journal of Biopharmaceutical Statistics|June 16, 2025
Assessing predictive probability of success for future clinical trialsArchie Sachdeva, Ram Tiwari, Ming ZhouJournal of Biopharmaceutical Statistics|January 22, 2013
Bayesian approach to assay sensitivity analysis of thorough QT trialsXiaoyu Dong, Xiao Ding, Yi TsongJournal of Biopharmaceutical Statistics|January 22, 2013
Considerations for design and data analysis of noninferiority/superiority cardiovascular trialsHui Quan, Mingyu Li, Peng-Liang Zhao, et al.Journal of Biopharmaceutical Statistics|January 22, 2013
Combining risk difference and risk ratio in noninferiority trials of safetyKristine R Broglio, Jason T Connor, Scott M BerryJournal of Biopharmaceutical Statistics|February 27, 2013
Minimal plus one point designs for testing lack of fit for some sigmoid curve modelsYing Su, Damaraju RaghavaraoPageof 216